Hospital Adoption and Pricing for Oncology Biosimilars
Hospital price markup margins from the administration of oncology biosimilars have increased over time and have been accompanied by large increases in the utilization of these therapies.
Authors
- Christopher Whaley (ORCID: https://orcid.org/0000-0002-9405-1989)
- J. E. M. Robinson (ORCID: https://orcid.org/0000-0002-2856-9413)
- Ari D Kosorukov
Institutions
- Brown University (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- JAMA
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1001/jama.2026.1777
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00